Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Figure 6
Cell viability was reduced by combined galectin-3 knockdown and ATO treatment.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Cell viability was reduced by combined galectin-3 knockdown and ATO treatment.